Covid19 — Coronaltitude - Multicentric Evaluation of the Impact on Hypoxia Sensitivity of Patients With COVID-19
Citation(s)
Algahtani H, Subahi A, Shirah B Neurological Complications of Middle East Respiratory Syndrome Coronavirus: A Report of Two Cases and Review of the Literature. Case Rep Neurol Med. 2016;2016:3502683. doi: 10.1155/2016/3502683. Epub 2016 Apr 28.
Bartsch P, Swenson ER Clinical practice: Acute high-altitude illnesses. N Engl J Med. 2013 Jun 13;368(24):2294-302. doi: 10.1056/NEJMcp1214870.
Basnyat B, Cumbo TA, Edelman R Infections at high altitude. Clin Infect Dis. 2001 Dec 1;33(11):1887-91. doi: 10.1086/324163. Epub 2001 Oct 19.
Cao Y, Liu X, Xiong L, Cai K Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis. J Med Virol. 2020 Sep;92(9):1449-1459. doi: 10.1002/jmv.25822. Epub 2020 Apr 10.
Coustet B, Lhuissier FJ, Vincent R, Richalet JP Electrocardiographic changes during exercise in acute hypoxia and susceptibility to severe high-altitude illnesses. Circulation. 2015 Mar 3;131(9):786-94. doi: 10.1161/CIRCULATIONAHA.114.013144. Epub 2015 Jan 5.
Couzin-Frankel J The mystery of the pandemic's 'happy hypoxia'. Science. 2020 May 1;368(6490):455-456. doi: 10.1126/science.368.6490.455. No abstract available.
Hackett PH, Roach RC High-altitude illness. N Engl J Med. 2001 Jul 12;345(2):107-14. doi: 10.1056/NEJM200107123450206. No abstract available.
Hackett PH The cerebral etiology of high-altitude cerebral edema and acute mountain sickness. Wilderness Environ Med. 1999 Summer;10(2):97-109. doi: 10.1580/1080-6032(1999)010[0097:tceoha]2.3.co;2.
Higgins V, Sohaei D, Diamandis EP, Prassas I COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2021 Aug;58(5):297-310. doi: 10.1080/10408363.2020.1860895. Epub 2020 Dec 21.
Hohenhaus E, Paul A, McCullough RE, Kucherer H, Bartsch P Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary oedema. Eur Respir J. 1995 Nov;8(11):1825-33. doi: 10.1183/09031936.95.08111825.
Li YC, Bai WZ, Hashikawa T The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
Luks AM, Grissom CK Return to High Altitude After Recovery from Coronavirus Disease 2019. High Alt Med Biol. 2021 Jun;22(2):119-127. doi: 10.1089/ham.2021.0049. Epub 2021 May 11.
Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 2020 Jul;194:105921. doi: 10.1016/j.clineuro.2020.105921. Epub 2020 May 15.
Neubauer JA, Melton JE, Edelman NH Modulation of respiration during brain hypoxia. J Appl Physiol (1985). 1990 Feb;68(2):441-51. doi: 10.1152/jappl.1990.68.2.441.
Nouri-Vaskeh M, Sharifi A, Khalili N, Zand R, Sharifi A Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism. Clin Neurol Neurosurg. 2020 Nov;198:106217. doi: 10.1016/j.clineuro.2020.106217. Epub 2020 Sep 9.
Richalet JP, Canoui-Poitrine F Pro: hypoxic cardiopulmonary exercise testing identifies subjects at risk for severe high altitude illnesses. High Alt Med Biol. 2014 Sep;15(3):315-7. doi: 10.1089/ham.2014.1032. No abstract available.
Richalet JP, Lhuissier FJ Aging, Tolerance to High Altitude, and Cardiorespiratory Response to Hypoxia. High Alt Med Biol. 2015 Jun;16(2):117-24. doi: 10.1089/ham.2015.0030. Epub 2015 May 6.
Salehi S, Reddy S, Gholamrezanezhad A Long-term Pulmonary Consequences of Coronavirus Disease 2019 (COVID-19): What We Know and What to Expect. J Thorac Imaging. 2020 Jul;35(4):W87-W89. doi: 10.1097/RTI.0000000000000534. No abstract available.
Zubieta-Calleja G, Zubieta-DeUrioste N, Venkatesh T, Das KK, Soliz J COVID-19 and Pneumolysis Simulating Extreme High-altitude Exposure with Altered Oxygen Transport Physiology; Multiple Diseases, and Scarce Need of Ventilators: Andean Condor's-eye-view. Rev Recent Clin Trials. 2020;15(4):347-359. doi: 10.2174/1574887115666200925141108.
Zubieta-Calleja G, Zubieta-DeUrioste N Pneumolysis and "Silent Hypoxemia" in COVID-19. Indian J Clin Biochem. 2021 Jan;36(1):112-116. doi: 10.1007/s12291-020-00935-0. Epub 2020 Nov 9.
Multicentric Evaluation of the Impact on Hypoxia Sensitivity of Patients With COVID-19
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.